Cell therapy for hereditary epidermolysis bullosa / 中华皮肤科杂志
Chinese Journal of Dermatology
;
(12): 698-702, 2023.
Article
in Chinese
| WPRIM
| ID: wpr-994516
ABSTRACT
Hereditary epidermolysis bullosa (EB) is a rare mutilating and lethal single-gene genodermatosis, and places a heavy burden on society and families. Cell therapy has become a very promising method for the treatment of EB due to its excellent and stable clinical efficacy. This review summarizes progress in laboratory research and clinical application of stem cell- and somatic cell-based therapies in EB in recent years.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Dermatology
Year:
2023
Type:
Article
Similar
MEDLINE
...
LILACS
LIS